Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Enhancing oral contraceptive success: the potential of new formulations.

AUTHORS

Kaunitz AM

SOURCE

American Journal of Obstetrics and Gynecology. 2004 Apr;190(4 Suppl 1):S23-S29.

ABSTRACT

Reductions in oral contraceptive (OC) estrogen dose and the development of new progestins have resulted in

formulations that maintain acceptable cycle control while improving safety. However, the potential safety benefits of

low-estrogen doses may be offset by less acceptable cycle control. These observations have led to the development

of 2 triphasic OC formulations containing norgestimate and desogestrel in combination with 25 mg ethinyl estradiol

(EE). Both of these 25-mg EE triphasic OCs balance fewer estrogen-related side effects with good cycle control

comparable to OCs containing higher estrogen doses. However, questions remain about the risk of venous

thromboembolism associated with OCs containing desogestrel. A new monophasic 30-mg EE OC contains

drospirenone, a spironolactone analogue with which there is limited experience. Although initial data with this OC

are intriguing, product labeling highlights safety issues related to its antimineralocorticoid effects and the potential

for hyperkalemia. Further experience with this formulation will determine its role in contraceptive practice.

(PubHealth.info Document ID: CONT1T 549-06)

PubHealth.info NOTE: The author(s) of this article titled, "Enhancing oral contraceptive success: the potential of new

formulations.", is(are) Kaunitz AM. The source of this article is "American Journal of Obstetrics and Gynecology.

2004 Apr;190(4 Suppl 1):S23-S29.". This article was published in 2004 in English language(s). (PubHealth.info®

Document ID: CONT1T 549-06. All rights reserved with PubHealth.info) PIN: 549

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.